RecruitingNot Applicable

Mesogastrium Metastasis in Colon Cancer

China50 participantsStarted 2021-01-12

Plain-language summary

Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of colorectal carcinoma * Preoperative staging cT2-4aN0M0 or cTanyN+M0 * tumor located at hepatic flexure or transverse colon close to flexures * Undergoing complete mesocolic excision with right gastric mesentery resection * Patients have to be aware of the aim of the trial, and have signed the informed consent. Exclusion Criteria: * Synchronous colorectal carcinoma * Clinical evidence of metastasis * History of colorectal cancer or other malignant tumors * Preoperative staging cT1N0 or cT4bNany * Emergency procedure

What they're measuring

metastasis rate

Timeframe: an average of 1 year

Trial details

NCT IDNCT04980287

SponsorJichao Qin

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-19

Contact for this trial

Jichao Qin, M.D./Ph.D

008613628683363 jcqin@tjh.thmu.edu.cn

View on ClinicalTrials.gov More Colon Cancer trials